Back
From Genomic Risk to Precision Prevention: Transforming Women's Cancer Care
Thursday, January 28, 2027 at 2:10 PM to 2:40 PM · 30 min. (Europe/London)
Pharmacogenomics & Patient Stratification Stage
Day 2 - Thursday 28th January
Cancer
Polygenic Risk Scores
Precision Medicine
Information
Using population genomic testing to identify individuals at increased risk of women's cancers.
Translating personalised risk assessment into targeted screening, surveillance and prevention.
Insights from ongoing genomic clinical trials in precision prevention.
The role of health economics and evidence generation in shaping national guidelines.
Scaling personalised prevention through digital tools and population-level implementation.
Speakers
Ranjit Manchanda
Professor of Gynaecological Oncology
Queen Mary University of London